Outsized

"Portal Biotech’s technology offers unprecedented capabilities in protein identification and characterisation, providing unmatched detail on protein structure and modifications at the single-molecule level on accessible desktop instruments that bring this state-of-the-art characterisation to any lab. These powerful advances are essential for accelerating drug discovery and enhancing diagnostic precision, positioning Portal Biotech as the frontrunner in the race to unlock the full potential of protein sequencing."

"Mixed reality has immense potential, demonstrated by the likes of Meta and Apple committing heavily to the sector. MixRift’s founding team has deep knowledge and experience, positioning the company to take advantage of both the demand from players and the growing interest in MR. We are pleased to be backing the team as MixRift grows."